caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1417272717

Mary RaddMSN, APN

Nurse PractitionerForked River, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
501
Unique beneficiaries
—
Total services
620
Distinct HCPCS
8
Medicare payment
$35K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 4,852 Nurse Practitioner providers in NJ — above median (cohort median 291).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$140
Payment records
2
By payment type
Food and Beverage$140
REFERRAL NETWORK

Where Mary Radd's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Dennis Novak
Family Practice · Forked River, NJ
1428
COMMUNITY MEDICAL CENTER INC1126
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Dennis Novak
Family Practice · Forked River, NJ
1631
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,328
Beneficiaries
—
Total drug cost
$100K
Distinct drugs
57
Brand share
10.4%
Top prescribed drugs
Atorvastatin Calcium247 claims
Levothyroxine Sodium178 claims
Losartan Potassium133 claims
Lisinopril106 claims
Amlodipine Besylate103 claims